Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 2
This trial looked at a number of different drugs to treat non small cell lung cancer (NSCLC). The treatment people had depended on the gene changes in their cancer cells.
The trial was supported by Cancer Research UK. It was open for people to join between 2015 and 2021. The research team have published some results but they plan to publish more in the future.
Recruitment start: 31 March 2015
Recruitment end: 31 October 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gary Middleton
Cancer Research UK
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Mirati Therapeutics
Pfizer
University of Birmingham
This is Cancer Research UK trial number CRUK/13/072.
Last reviewed: 1 July 2025
CRUK internal database number: 11152
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
